The Blood Grouping Reagents Market size value per capita in Brazil experienced a gradual decline from 2012 to 2022. Starting at 0.23 percent of US dollars per capita in 2012, it fell steadily to 0.18 by 2022. The year-on-year decrease has leveled off in recent years, with the value stable at 0.18 since 2020, indicating a slight stabilization in the market.
- Variation from 2022 to 2023 showed stability as no significant changes were noted.
- The compound annual growth rate (CAGR) over the last five years reflects a slight negative trend, showing an average annual decline in value.
Looking forward, increased investment in healthcare infrastructure and technological advancements in reagent development could influence future growth. Monitoring regulations and innovations in the diagnostic space will be crucial for understanding shifts in this market.
| # | 13 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Spain | 2.14 | 2023 | View data | ||
| 2 | 2 United Kingdom | 1.64 | 2023 | View data | ||
| 3 | 3 Italy | 1.52 | 2023 | View data | ||
| 4 | 4 Greece | 1.35 | 2023 | View data | ||
| 5 | 5 Croatia | 1.01 | 2023 | View data | ||
| 11 | 11 Australia | 0.36 | 2023 | View data | ||
| 12 | 12 Thailand | 0.3 | 2023 | View data | ||
| 13 | 13 Brazil | 0.16 | 2023 | |||
